Cost of Biologic Treatment Persistence or Switching in Rheumatoid Arthritis
Patients with rheumatoid arthritis who switched biologics incurred higher costs than patients who persisted on biologics. Etanercept appeared to be associated with the lowest costs.
Reimbursement Landscape for Molecular Testing in Non-Small Cell Lung Cancer
This review assesses the current molecular testing landscape for non–small-cell lung cancer in the United States.
eAppendix
